Concord Drugs Ltd

Concord Drugs Ltd | Sector: Pharmaceuticals | ISIN: INE858L01010

Trade

Corporate Actions

02 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Feb , 2023

12:00 AM

Results

View Details

03 Nov , 2022

12:00 AM

Results

View Details

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Sep , 2022

12:00 AM

AGM

Announcement date: 08 Sep , 2022

View Details

03 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Aug , 2022

12:00 AM

EGM

View Details

13 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Aug , 2022

12:00 AM

Results

View Details

28 Jul , 2022

12:00 AM

Results

View Details

28 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2022

12:00 AM

Results

View Details

06 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Sep , 2022

12:00 AM

BookCloser

View Details

Concord Drugs Ltd News and Update

Adani Power sells Support Properties Private Ltd to AdaniConnex

7 hours ago |
4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Power Grid Corporation acquires Khavda II-C Transmission Ltd

1 day ago |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
1 day ago |
4:02 PM

Govt to sell up to 3.5% stake in HAL

IIFL News Service |
1 day ago |
4:02 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	975.45	90.41	2,34,487.01	486.73	1.02	4,549.90	108.48
Divis Laboratories Ltd	2,808.60	31.35	74,359.08	310.90	1.07	1,689.83	454.85
Dr Reddys Laboratories Ltd	4,465.25	31.39	74,070.86	324.60	0.67	3,879.60	1,156.21
Cipla Ltd	874.00	25.36	70,181.74	678.52	0.57	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,515.00	49.41	51,822.77	229.00	1.57	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Concord Drugs Ltd

S Nagi Reddy
Chairman & Managing Director

K Ramchandra Reddy
Independent Director

Koni Reddy
Whole Time Director & CFO

S. Nagavenkata Hareesh
Independent Director

S. Manoj Kumar Reddy
Whole-time Director

Summela Kasu
Independent Director

Summary

Summary Info Not Found

Reports by Concord Drugs Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Concord Drugs Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Concord Drugs Ltd

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 24 March , 2023 | 02:15 PM

Knowledge Center

Concord Drugs Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Concord Drugs Ltd

S Nagi Reddy

K Ramchandra Reddy

Koni Reddy

S. Nagavenkata Hareesh

S. Manoj Kumar Reddy

Summela Kasu

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
24 March , 2023 | 02:15 PM